Unknown drug manufacturing company · Reality · violation
KSPCB recommended ₹11.68 Crore fine for environmental violations by drug manufacturing company.
High G-score driven by regulatory violations (5/5) from state pollution control board enforcement action with substantial ₹11.68 Crore fine indicating serious environmental compliance failures. Drug manufacturing typically involves chemical processes with potential toxic releases (4/5). Accountability severity multiplier of 1.3 applied as this is regulator-discovered willful violation. Zero C-score as this is purely a regulatory enforcement action with no corporate sustainability claims present. Clear List R classification as environmental harm dominates with no greenwashing component.
KSPCB recommended ₹11.68 Crore fine for environmental violations by drug manufacturing company
Data sourced from EPA ECHO, GDELT, PR Newswire, and other public sources. Scores are algorithmically generated and may not reflect complete context.